Drugs from the seas - current status and microbiological implications

Area of Science:

• Marine natural products chemistry
• Microbial biosynthesis
• Drug discovery

Background:

• Marine invertebrates, including sponges, tunicates, bryozoans, and molluscs, accumulate structurally unique natural products.
• Several marine-derived compounds exhibit potent pharmacological activities, showing promise for drug development, especially in oncology.
• Marine natural products often share structural similarities with microbial metabolites, suggesting a microbial origin or involvement in biosynthesis.

Purpose of the Study:

• To explore the origin and biosynthesis of marine natural products.
• To investigate the role of symbiotic microorganisms in the production of bioactive compounds from marine invertebrates.
• To highlight the potential of marine natural products as novel therapeutic agents.

Main Methods:

• Analysis of natural products from marine invertebrates.
• Investigation of microbial diversity in marine organisms using molecular methods.
• Studies on the localization of compounds within symbiotic bacteria and cyanobacteria.

Main Results:

• Marine invertebrates are a rich source of unique natural products with demonstrated pharmacological activities.
• Evidence suggests that microorganisms, such as bacteria and microalgae, are involved in or are the primary producers of many marine invertebrate metabolites.
• Molecular studies confirm the presence of specific bacteria in marine sponges and their potential role in synthesizing compounds like bryostatins.

Conclusions:

• Marine natural products represent a promising area for novel drug discovery, particularly for cancer, pain management, and anti-inflammatory therapies.
• Symbiotic microorganisms within marine invertebrates are crucial for the biosynthesis of many valuable natural products.
• Advanced molecular techniques are essential for uncovering the microbial sources and biosynthetic pathways of these important compounds.